Sara Lundqvist
Overview
Explore the profile of Sara Lundqvist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lundqvist S, Rojas S, Bador K, Rastam M, Kerekes N
Front Psychiatry
. 2025 Feb;
16:1534280.
PMID: 40007889
Introduction: Attention-deficit/hyperactivity disorder (ADHD) frequently exists alongside psychiatric comorbidities. The coexistence of somatic diseases and ADHD constitutes a growing field of research. Method: This study aimed to examine the prevalence...
2.
Haggag A, Butcher L, Pagnussat S, Davies G, Lundqvist S, Wang W, et al.
Diabetes Obes Metab
. 2024 Nov;
27(2):551-562.
PMID: 39495140
Aims: GLP-1 receptor agonists (GLP-1 RAs) are proven therapies for type 2 diabetes mellitus (T2DM) and overweight or obesity. We performed non-clinical and first-in-human (FIH) evaluation of ECC5004/AZD5004, an oral...
3.
Lundqvist S, Knez R, Nagy K, Nasic S, Kerekes N, Kantzer A
Paediatr Neonatal Pain
. 2023 Jun;
5(2):50-56.
PMID: 37283952
The prevalence of pain in children and adolescents with psychiatric conditions is rarely investigated. The aims of the current study were to (a) describe the prevalence of headaches and abdominal...
4.
Kerekes N, Lundqvist S, Schubert Hjalmarsson E, Torinsson Naluai A, Kantzer A, Knez R
PLoS One
. 2022 Sep;
17(9):e0273653.
PMID: 36083951
New research shows that the prevalence of neurodevelopmental disorders, such as attention-deficit/hyperactivity disorder (ADHD), is increased in children and adolescents as well as in adults with chronic pain, compared to...
5.
Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoring
Zetterstrom A, Dahlberg G, Lundqvist S, Hamalainen M, Winkvist M, Nyberg F, et al.
PLoS One
. 2022 Jul;
17(7):e0271465.
PMID: 35834544
Purpose: eHealth systems allow efficient daily smartphone-based collection of self-reported data on mood, wellbeing, routines, and motivation; however, missing data is frequent. Within addictive disorders, missing data may reflect lack...
6.
Cooper M, Llinas A, Hansen P, Caffrey M, Ray A, Sjodin S, et al.
J Med Chem
. 2020 Aug;
63(17):9705-9730.
PMID: 32787075
Muscle atrophy and cachexia are common comorbidities among patients suffering from cancer, chronic obstructive pulmonary disease, and several other chronic diseases. The peptide hormone ghrelin exerts pleiotropic effects including the...
7.
[Dropout from Specialty Training is determined by the perception of autonomy and treatment efficacy]
Blechinger T, Lundqvist S, Buchmayer S, Hallerback M, Jarbin H
Lakartidningen
. 2019 Aug;
116.
PMID: 31454053
The Swedish Association for Child and Adolescent Psychiatry conducted a survey among their specialty trainees in 2018. Of the 48% response rate, around 48% admitted hesitancy to continue in their...
8.
Lundqvist S, Modvig S, Fischer E, Frederiksen J, Degn M
Immunology
. 2018 Nov;
156(3):259-269.
PMID: 30452090
Mouse models of multiple sclerosis (MS) have shown the importance of interleukin-10 (IL-10) -producing regulatory B (Breg) cells in dampening disease activity and inhibiting disease initiation and progression. In MS...
9.
Axelsson H, Almqvist H, Otrocka M, Vallin M, Lundqvist S, Hansson P, et al.
ACS Chem Biol
. 2018 Feb;
13(4):942-950.
PMID: 29433316
A prerequisite for successful drugs is effective binding of the desired target protein in the complex environment of a living system. Drug-target engagement has typically been difficult to monitor in...
10.
Fjellstrom O, Larsson N, Yasuda S, Tsuchida T, Oguma T, Marley A, et al.
PLoS One
. 2016 Jan;
10(12):e0145849.
PMID: 26720709
Type 2 diabetes (T2D) occurs when there is insufficient insulin release to control blood glucose, due to insulin resistance and impaired β-cell function. The GPR39 receptor is expressed in metabolic...